2269.HK
Wuxi Biologics (Cayman) Inc.
HK$33.34
+2.96%
2026-05-29
About Wuxi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (TAA) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
Key Fundamentals
P/E Ratio
24.88
Forward P/E
16.94
EPS (TTM)
HK$1.34
ROE
11.6%
Revenue Growth (YoY)
17.2%
Profit Margin
22.5%
Debt/Equity
5.85
Price/Book
2.52
Beta
0.58
Market Cap
HK$137.96B
Avg Volume (10D)
28.3M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
HK$39.88
60D Low
HK$30.94
Avg Volume
28.6M
Latest Close
HK$33.34
Get breakout alerts for 2269.HK
Sign up for Breakout Scanner to receive daily notifications when 2269.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Wuxi Biologics (Cayman) Inc. (2269.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2269.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2269.HK operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.